TRIM65
protein-codingtripartite motif containing 65, the group of Tripartite motif family|Ring finger proteins
Gene summary
Enables protein domain specific binding activity and ubiquitin protein ligase activity. Involved in several processes, including positive regulation of interferon-beta production; protein K48-linked ubiquitination; and regulation of defense response. Acts upstream of or within innate immune response; positive regulation of protein oligomerization; and protein K63-linked ubiquitination. Located in cytosol and nucleoplasm. Is active in cytoplasm. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRIM65 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_173547.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 106 | 7 | 113 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 109 | 8 | 0 | 117 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_775818.2 | 6 | MANE Select | |
| Ensembl | ENSP00000269383.3 | 6 | MANE Select | |
| RefSeq | NP_001243053.1 | 5 | Standard | |
| Ensembl | ENSP00000444607.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- positive regulation of autophagy
Molecular Function
- zinc ion binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000269383
- Coding exons
- 6
- Length
- 16669
- Individuals with no LoFs
- 125600
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 141
- Defined
- 125741
- p
- 0.000561
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.408 | 235 | 253 | 0.928 | 0.0000152 | 3223 |
| Missense (PolyPhen) | 75 | 77.16 | 0.972 | 1059 | ||
| Synonymous | 0.613 | 107 | 115 | 0.927 | 0.00000704 | 1095 |
| Loss of Function | -1.59 | 27 | 19.4 | 1.39 | 9.03e-7 | 214 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0042 | 0.0042 | notable |
| Finnish | 0.00047 | 0.00028 | rare |
| European (Non-Finnish) | 0.00028 | 0.00027 | rare |
| South Asian | 0.00049 | 0.00049 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
Intolerance Scores
- LoFtool
- 0.753
- RVIS EVS
- 0.78
- RVIS percentile EVS
- 87.21
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.488
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |